Cerity Partners’s Tandem Diabetes Care TNDM Stock Holding History

Cerity Partners’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.15M	Sell	76,122 -106	-0.1%	-$1.85K	﹤0.01%	1920
2026 Q1	$1.46M	Sell	76,228 -543	-0.7%	-$11.8K	﹤0.01%	1645
2025 Q4	$1.69M	Buy	76,771 +472	+0.6%	+$8.52K	﹤0.01%	1445
2025 Q3	$926K	Sell	76,299 -5,963	-7%	-$80.7K	﹤0.01%	1630
2025 Q2	$1.53M	Buy	82,262 +6,257	+8%	+$124K	﹤0.01%	1338
2025 Q1	$1.46M	Buy	76,005 +18,529	+32%	+$542K	﹤0.01%	1261
2024 Q4	$2.43M	Sell	57,476 -5,320	-8%	-$180K	0.01%	1017
2024 Q3	$2.66M	Buy	62,796 +11,247	+22%	+$477K	0.01%	963
2024 Q2	$2.08M	Sell	51,549 -5,843	-10%	-$244K	0.01%	900
2024 Q1	$2.03M	Buy	+57,392	New	+$1.54M	0.01%	958

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

FGP

Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cerity Partners's TNDM Position: Q2 2026 in Review

Cerity Partners reduced its Tandem Diabetes Care (TNDM) stake by 0.14% in Q2 2026, selling an estimated $1.85K and leaving 76,122 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1920.

Cerity Partners first reported a position in TNDM in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.66M in Q3 2024. 252 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

Cerity Partners held 76,122 shares of Tandem Diabetes Care worth $1.15M as of Q2 2026.
Cerity Partners sold 106 Tandem Diabetes Care shares in Q2 2026, an estimated $1.85K.
Tandem Diabetes Care made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1920 holding.
Cerity Partners first reported a position in Tandem Diabetes Care in Q1 2024 and has held it in 10 quarters since.
Cerity Partners's Tandem Diabetes Care position peaked at $2.66M in Q3 2024.
252 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.